Fifth Third Bancorp
RYTM icon

Fifth Third Bancorp’s Rhythm Pharmaceuticals RYTM Stock Holding History

Fifth Third Bancorp’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$476K Sell
4,290
-970
-18% -$87.7K ﹤0.01% 2125
2026
Q1 		$457K Buy
+5,260
New +$512K ﹤0.01% 2083
2019
Q4 		– Sell
-137
Closed -$3K – 2326
2019
Q3 		$3K Buy
+137
New +$2.94K ﹤0.01% 2012

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fifth Third Bancorp's RYTM Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Rhythm Pharmaceuticals (RYTM) stake by 18% in Q2 2026, selling an estimated $87.7K and leaving 4,290 shares worth $476K. The position accounts for ﹤0.01% of the portfolio, ranked #2125.

Fifth Third Bancorp first reported a position in RYTM in Q3 2019 and has held it in 3 quarters since. 303 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Fifth Third Bancorp held 4,290 shares of Rhythm Pharmaceuticals worth $476K as of Q2 2026.
  • Fifth Third Bancorp sold 970 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $87.7K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #2125 holding.
  • Fifth Third Bancorp first reported a position in Rhythm Pharmaceuticals in Q3 2019 and has held it in 3 quarters since.
  • 303 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.